Impact of Surgical Treatment on Outcomes for Papillary Thyroid Cancer

Advances in Surgery

Volumn 42, Issue C, 2008, Pages 1-12

  Bilimoria, Karl Y ^a,b   Zanocco, Kyle ^a   Sturgeon, Cord ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; METHODOLOGY; PAPILLARY CARCINOMA; REVIEW; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA, PAPILLARY; HUMANS; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 49849104004     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2008.03.001     Document Type: Review

References (32)

1. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 18 (2006) 2164-2167
2. Shaha A.R., Shah J.P., and Loree T.R. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 4 4 (1997) 328-333
3. Mazzaferri E.L., and Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97 5 (1994) 418-428
4. Hay I.D., Grant C.S., Taylor W.F., et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102 6 (1987) 1088-1095
5. Hay I.D., Bergstralh E.J., Goellner J.R., et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114 6 (1993) 1050-1057 [discussion: 1057-8]
6. Hay I.D., Grant C.S., Bergstralh E.J., et al. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?. Surgery 124 6 (1998) 958-964 [discussion: 964-6]
7. Udelsman R., and Shaha A.R. Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer?. Lancet Oncol 6 7 (2005) 529-531
8. Hundahl S.A., Cady B., Cunningham M.P., et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89 1 (2000) 202-217
9. Sosa J.A., Bowman H.M., Tielsch J.M., et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228 3 (1998) 320-330
10. Russell W.O., Ibanez M.L., Clark R.L., et al. Thyroid carcinoma. Classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer 16 (1963) 1425-1460
11. Katoh R., Sasaki J., Kurihara H., et al. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patients. Cancer 70 6 (1992) 1585-1590
12. Caillou B., Troalen F., Baudin E., et al. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study. J Clin Endocrinol Metab 83 11 (1998) 4102-4106
13. Jhiang S.M., Cho J.Y., Ryu K.Y., et al. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139 10 (1998) 4416-4419
14. Lin J.D., Hsueh C., Chao T.C., et al. Expression of sodium iodide symporter in benign and malignant human thyroid tissues. Endocr Pathol 12 1 (2001) 15-21
15. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246 3 (2007) 375-381 [discussion: 381-4]
16. Samaan N.A., Maheshwari Y.K., Nader S., et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56 6 (1983) 1131-1138
17. Clark O.H. Papillary Thyroid carcinoma: rationale for total thyroidectomy. In: Clark O.H., Duh Q.Y., and Kebebew E. (Eds). Textbook of endocrine surgery (2005), Elsevier Saunders, Philadelphia 110-114
18. DeGroot L.J., Kaplan E.L., McCormick M., et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71 2 (1990) 414-424
19. Sanders L.E., and Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 133 4 (1998) 419-425
20. Hay I.D., Thompson G.B., Grant C.S., et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26 8 (2002) 879-885
21. Haigh P.I., Urbach D.R., and Rotstein L.E. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 12 1 (2005) 81-89
22. Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. [see comments]. Cancer 83 12 (1998) 2638-2648
23. Jonklaas J., Sarlis N.J., Litofsky D., et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16 12 (2006) 1229-1242
24. Tsang R.W., Brierley J.D., Simpson W.J., et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82 2 (1998) 375-388
25. Cady B., and Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104 6 (1988) 947-953
26. Mazzaferri E.L., Young R.L., Oertel J.E., et al. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore) 56 3 (1977) 171-196
27. Mazzaferri E.L., and Young R.L. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70 3 (1981) 511-518
28. Kebebew E., Duh Q.Y., and Clark O.H. Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. World J Surg 24 11 (2000) 1295-1302
29. Udelsman R., Lakatos E., and Ladenson P. Optimal surgery for papillary thyroid carcinoma. World J Surg 20 1 (1996) 88-93
30. Bilimoria K., Bentrem D., Linn J.G., et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 142 6 (2007) 906-913
31. Haigh P.I., Urbach D.R., and Rotstein L.E. AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery 136 3 (2004) 609-616
32. Clark O.H. Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 196 3 (1982) 361-370